{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:45:42Z","timestamp":1791384342452,"version":"4.3.3"},"reference-count":29,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atherosclerosis and chemokines are strongly related, but the role of the chemokine CXCL17 in atherogenesis is still poorly understood. We aim to investigate the serum CXCL17 levels in different stages of patients with coronary heart disease and explore whether these differences contribute to atherosclerosis. In the current prospective study, we enrolled 48 patients with unstable angina (UA), 51 patients with stable angina (SA) and 41 patients for the control group (CG). All subjects were diagnosed by coronary angiography and Gensini score was used to evaluate the severity of coronary artery disease. The CXCL17 levels were determined using ELISA, while lipid metabolism indicators and high sensitivity C-reactive protein (hs-CRP) were detected by automatic biochemical analyzer. We observed that the unstable angina group had higher CXCL17 levels compared with the stable angina and the control group. The logistic regression analysis showed that CXCL17 was an independent risk factor for unstable angina. Our results showed that CXCL17 was also statistically correlated with hs-CRP, while it was irrelevant with Gensini score. CXCL17 levels were associated with activity of inflammatory response and the instability of atherosclerotic plaques. These results suggest that CXCL17 elevation may be a potential new biomarker of unstable angina.<\/jats:p>","DOI":"10.1515\/med-2019-0080","type":"journal-article","created":{"date-parts":[[2019,12,8]],"date-time":"2019-12-08T04:02:52Z","timestamp":1575777772000},"page":"939-944","source":"Crossref","is-referenced-by-count":6,"title":["Association between unstable angina and CXCL17: a new potential biomarker"],"prefix":"10.1515","volume":"14","author":[{"given":"Fu-han","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qiang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tongren Municipal People\u2019s Hospital , Tongren 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongren Municipal People\u2019s Hospital , Tongren 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-lin","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-sheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongren Municipal People\u2019s Hospital , No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District , Tongren City 554300 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,12,8]]},"reference":[{"key":"2026012107370035596_j_med-2019-0080_ref_001","doi-asserted-by":"crossref","unstructured":"Zhang Y.,Li H. Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases, Physiology (Bethesda), 2017, 32, 210-223","DOI":"10.1152\/physiol.00038.2016"},{"key":"2026012107370035596_j_med-2019-0080_ref_002","doi-asserted-by":"crossref","unstructured":"Zhang Y., Zhang X. J., Wang P. X., Zhang P.,Li H. Reprogramming Innate Immune Signaling in Cardiometabolic Disease, Hypertension, 2017, 69, 747-760","DOI":"10.1161\/HYPERTENSIONAHA.116.08192"},{"key":"2026012107370035596_j_med-2019-0080_ref_003","doi-asserted-by":"crossref","unstructured":"Divorty N., Mackenzie A. E., Nicklin S. A.,Milligan G. G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease, Front Pharmacol, 2015, 6, 41","DOI":"10.3389\/fphar.2015.00041"},{"key":"2026012107370035596_j_med-2019-0080_ref_004","doi-asserted-by":"crossref","unstructured":"Maravillas-Montero J. L., Burkhardt A. M., Hevezi P. A., Carnevale C. D., Smit M. J.,Zlotnik A. Cutting edge: GPR35\/ CXCR8 is the receptor of the mucosal chemokine CXCL17, J Immunol, 2015, 194, 29-33","DOI":"10.4049\/jimmunol.1401704"},{"key":"2026012107370035596_j_med-2019-0080_ref_005","doi-asserted-by":"crossref","unstructured":"Weinstein E. J., Head R., Griggs D. W., Sun D., Evans R. J., Swearingen M. L.,et al. VCC-1, a novel chemokine, promotes tumor growth, Biochem Biophys Res Commun, 2006, 350, 74-81","DOI":"10.1016\/j.bbrc.2006.08.194"},{"key":"2026012107370035596_j_med-2019-0080_ref_006","doi-asserted-by":"crossref","unstructured":"Ohlsson L., Hammarstrom M. L., Lindmark G., Hammarstrom S.,Sitohy B. Ectopic expression of the chemokine CXCL17 in colon cancer cells, Br J Cancer, 2016, 114, 697-703","DOI":"10.1038\/bjc.2016.4"},{"key":"2026012107370035596_j_med-2019-0080_ref_007","doi-asserted-by":"crossref","unstructured":"Lee W. Y., Wang C. J., Lin T. Y., Hsiao C. L.,Luo C. W. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor, Am J Physiol Endocrinol Metab, 2013, 304, E32-40","DOI":"10.1152\/ajpendo.00083.2012"},{"key":"2026012107370035596_j_med-2019-0080_ref_008","unstructured":"Hernandez-Diaz Y., Tovilla-Zarate C. A., Juarez-Rojop I., Banos-Gonzalez M. A., Torres-Hernandez M. E., Lopez-Narvaez M. L.,et al. The role of gene variants of the inflammatory markers CRP and TNF-alpha in cardiovascular heart disease: systematic review and meta-analysis, Int J Clin Exp Med, 2015, 8, 11958-11984"},{"key":"2026012107370035596_j_med-2019-0080_ref_009","doi-asserted-by":"crossref","unstructured":"Chen L., Sun M., Liu H., Ma L., Wang T., Li P.,et al. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-alpha contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China, Lipids Health Dis, 2018, 17, 176","DOI":"10.1186\/s12944-018-0830-5"},{"key":"2026012107370035596_j_med-2019-0080_ref_010","doi-asserted-by":"crossref","unstructured":"Neeland I. J., Patel R. S., Eshtehardi P., Dhawan S., McDaniel M. C., Rab S. T.,et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity, Am Heart J, 2012, 164, 547-552 e541","DOI":"10.1016\/j.ahj.2012.07.007"},{"key":"2026012107370035596_j_med-2019-0080_ref_011","doi-asserted-by":"crossref","unstructured":"Ikejima H., Imanishi T., Tsujioka H., Kashiwagi M., Kuroi A., Tanimoto T.,et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris, Circ J, 2010, 74, 337-345","DOI":"10.1253\/circj.CJ-09-0484"},{"key":"2026012107370035596_j_med-2019-0080_ref_012","doi-asserted-by":"crossref","unstructured":"Li R. J., Yang M., Li J. F., Xue L., Chen Y. G.,Chen W. Q. Circulating CD36 and fractalkine levels are associated with vulnerable plaque progression in patients with unstable angina pectoris, Clin Exp Pharmacol Physiol, 2014, 41, 863-869","DOI":"10.1111\/1440-1681.12302"},{"key":"2026012107370035596_j_med-2019-0080_ref_013","doi-asserted-by":"crossref","unstructured":"de Oliveira R. T., Mamoni R. L., Souza J. R., Fernandes J. L., Rios F. J., Gidlund M.,et al. Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease, Int J Cardiol, 2009, 136, 17-26","DOI":"10.1016\/j.ijcard.2008.04.009"},{"key":"2026012107370035596_j_med-2019-0080_ref_014","doi-asserted-by":"crossref","unstructured":"Ye Y., Yang X., Zhao X., Chen L., Xie H., Zeng Y.,et al. Serum chemokine CCL17\/thymus activation and regulated chemokine is correlated with coronary artery diseases, Atherosclerosis, 2015, 238, 365-369","DOI":"10.1016\/j.atherosclerosis.2014.12.047"},{"key":"2026012107370035596_j_med-2019-0080_ref_015","doi-asserted-by":"crossref","unstructured":"Kraaijeveld A. O., de Jager S. C., de Jager W. J., Prakken B. J., McColl S. R., Haspels I.,et al. CC chemokine ligand-5 (CCL5\/ RANTES) and CC chemokine ligand-18 (CCL18\/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms, Circulation, 2007, 116, 1931-1941","DOI":"10.1161\/CIRCULATIONAHA.107.706986"},{"key":"2026012107370035596_j_med-2019-0080_ref_016","doi-asserted-by":"crossref","unstructured":"Damas J. K., Boullier A., Waehre T., Smith C., Sandberg W. J., Green S.,et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy, Arterioscler Thromb Vasc Biol, 2005, 25, 2567-2572","DOI":"10.1161\/01.ATV.0000190672.36490.7b"},{"key":"2026012107370035596_j_med-2019-0080_ref_017","doi-asserted-by":"crossref","unstructured":"Li L., Yan J., Xu J., Liu C. Q., Zhen Z. J., Chen H. W.,et al. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma, PLoS One, 2014, 9, e110064","DOI":"10.1371\/journal.pone.0110064"},{"key":"2026012107370035596_j_med-2019-0080_ref_018","doi-asserted-by":"crossref","unstructured":"Koringa P. G., Jakhesara S. J., Bhatt V. D., Meshram C. P., Patel A. K., Fefar D. T.,et al. Comprehensive transcriptome profiling of squamous cell carcinoma of horn in Bos indicus, Vet Comp Oncol, 2016, 14, 122-136","DOI":"10.1111\/vco.12079"},{"key":"2026012107370035596_j_med-2019-0080_ref_019","doi-asserted-by":"crossref","unstructured":"Tucureanu M. M., Butoi E., Gan A. M., Stan D., Constantinescu C. A., Calin M.,et al. Amendment of the cytokine profile in macrophages subsequent to their interaction with smooth muscle cells: Differential modulation by fractalkine and resistin, Cytokine, 2016, 83, 250-261","DOI":"10.1016\/j.cyto.2016.04.019"},{"key":"2026012107370035596_j_med-2019-0080_ref_020","doi-asserted-by":"crossref","unstructured":"Burkhardt A. M., Maravillas-Montero J. L., Carnevale C. D., Vilches-Cisneros N., Flores J. P., Hevezi P. A.,et al. CXCL17 is a major chemotactic factor for lung macrophages, J Immunol, 2014, 193, 1468-1474","DOI":"10.4049\/jimmunol.1400551"},{"key":"2026012107370035596_j_med-2019-0080_ref_021","doi-asserted-by":"crossref","unstructured":"Niccoli G., Liuzzo G., Montone R. A.,Crea F. Advances in mechanisms, imaging and management of the unstable plaque, Atherosclerosis, 2014, 233, 467-477","DOI":"10.1016\/j.atherosclerosis.2014.01.036"},{"key":"2026012107370035596_j_med-2019-0080_ref_022","doi-asserted-by":"crossref","unstructured":"Zhang Y., Tan S., Xu J.,Wang T. Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside, Cell Physiol Biochem, 2018, 47, 1-10","DOI":"10.1159\/000489737"},{"key":"2026012107370035596_j_med-2019-0080_ref_023","doi-asserted-by":"crossref","unstructured":"Alber H. F., Suessenbacher A.,Weidinger F. [The role of inflammation in the pathophysiology of acute coronary syndromes], Wien Klin Wochenschr, 2005, 117, 445-455","DOI":"10.1007\/s00508-005-0399-7"},{"key":"2026012107370035596_j_med-2019-0080_ref_024","doi-asserted-by":"crossref","unstructured":"Brunetti N. D., Correale M., Pellegrino P. L., Cuculo A.,Biase M. D. Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings, Eur J Intern Med, 2007, 18, 109-117","DOI":"10.1016\/j.ejim.2006.07.031"},{"key":"2026012107370035596_j_med-2019-0080_ref_025","doi-asserted-by":"crossref","unstructured":"Brunetti N. D., Troccoli R., Correale M., Pellegrino P. L.,Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings, Int J Cardiol, 2006, 109, 248-256","DOI":"10.1016\/j.ijcard.2005.06.021"},{"key":"2026012107370035596_j_med-2019-0080_ref_026","doi-asserted-by":"crossref","unstructured":"Seo W. W., Kim H. L., Kim Y. J., Yoon Y. E., Lee S. P., Kim H. K.,et al. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography, J Cardiol, 2016, 68, 222-228","DOI":"10.1016\/j.jjcc.2015.09.010"},{"key":"2026012107370035596_j_med-2019-0080_ref_027","unstructured":"Seyedian S. M., Ahmadi F., Dabagh R.,Davoodzadeh H. Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease, ARYA Atheroscler, 2016, 12, 231-237"},{"key":"2026012107370035596_j_med-2019-0080_ref_028","doi-asserted-by":"crossref","unstructured":"Zakynthinos E.,Pappa N. Inflammatory biomarkers in coronary artery disease, J Cardiol, 2009, 53, 317-333","DOI":"10.1016\/j.jjcc.2008.12.007"},{"key":"2026012107370035596_j_med-2019-0080_ref_029","doi-asserted-by":"crossref","unstructured":"Gong F. H., Cheng W. L., Wang H., Gao M., Qin J. J., Zhang Y.,et al. Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects, J Lipid Res, 2018, 59, 658-669","DOI":"10.1194\/jlr.M082651"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/med\/14\/1\/article-p939.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0080\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0080\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:38:10Z","timestamp":1768981090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0080\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,20]]},"published-print":{"date-parts":[[2019,2,20]]}},"alternative-id":["10.1515\/med-2019-0080"],"URL":"https:\/\/doi.org\/10.1515\/med-2019-0080","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}